Follow APCER: 

APCER Life Sciences Launches Quality Assurance Auditing
and Consultancy Services

New offering meets growing demand for expertise in compliance across pharmaceutical companies’ clinical and post-marketing ecosystem 

London, UK – March 29, 2017 – via Globe Newswire  APCER Life Sciences, the truly global provider of safety, medical, regulatory and technology services, announced the availability of Quality Assurance (QA) Auditing and Consultancy as a stand-alone service.

Photo of Mike Britt

Mike Britt

Photo of Luke Keitel

Luke Keitel

“Today’s announcement is really a formalization of a capability that many of our current clients have already taken advantage of. We have grown our global Quality and Compliance organization to the size where we feel confident to offer our specialized expertise to the industry as a stand-alone service apart from support of our operational clients in clinical safety, post-marketing pharmacovigilance, and medical affairs.”

-- Michael Britt, Head of the EU business unit for APCER Life Sciences

“Our QA Auditing and Consultancy services draw on the experience of a global team of expert auditors and other QA professionals to help pharmaceutical companies meet their regulatory obligations. The offering is in direct response to the escalating complexity and cost of compliance that has driven organisations to outsource more of their audits to specialist service providers.”

-- Luke Keitel, Global Head of Quality and Compliance at APCER Life Sciences

APCER will offer a wide range of audits, including:

  • Good Pharmacovigilance Practice
  • Good Clinical Practice
  • Good Manufacturing Practice
  • Information Technology & Computer Systems Validation
  • Vendors

Consultancy in the following areas is also available:

  • Quality Risk Management
  • Inspection Preparation & Training
  • Mock Inspections
  • Gap Analysis
  • Quality Management Systems
  • Learning Management